エリスロポエチンのグローバル市場 2021年：企業別、地域別、種類・用途別

• 英文タイトル：Global Erythropoietin Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-203B16154 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、86ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

エリスロポエチン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のエリスロポエチンの市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界のエリスロポエチンの市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。 エリスロポエチン市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・エポエチンアルファ、エポエチンベータ、ダルベポエチンアルファ、その他 用途別セグメントは次のように区分されます。 ・貧血、腎臓障害、その他 世界のエリスロポエチン市場の主要な市場プレーヤーは以下のとおりです。 ・Amgen、Johnson & Johnson、Roche、Galenica、Emcure、Kyowa Hakko Kirin、3SBio、Biocon、LG Life Sciences 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計14章あります。 ・第1章では、エリスロポエチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なエリスロポエチンメーカーの企業概要、2019年～2021年までのエリスロポエチンの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なエリスロポエチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年～2026年までの地域別エリスロポエチンの販売量、売上、成長性を示しています。 ・第5、6章では、2016年～2026年までのエリスロポエチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域でのエリスロポエチン市場予測を収録しています。 ・第12、13、14章では、エリスロポエチンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Amgen、Johnson & Johnson、Roche、Galenica、Emcure、Kyowa Hakko Kirin、3SBio、Biocon、LG Life Sciences ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：エポエチンアルファ、エポエチンベータ、ダルベポエチンアルファ、その他 ・用途別分析2016年-2026年：貧血、腎臓障害、その他 ・エリスロポエチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・エリスロポエチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・エリスロポエチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・エリスロポエチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・エリスロポエチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Erythropoietin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Erythropoietin size is estimated to be XX million in 2021 from USD 8907.6 million in 2020, with a change of XX% between 2020 and 2021. The global Erythropoietin market size is expected to grow at a CAGR of 5.6% for the next five years.

Market segmentation
Erythropoietin market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Epoetin-alfa
Epoetin-beta
Darbepoetin-alfa
Others

Market segment by Application can be divided into
Anemia
Kidney Disorders
Others

The key market players for global Erythropoietin market are listed below:
Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio
Biocon
LG Life Sciences

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Erythropoietin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Erythropoietin, with price, sales, revenue and global market share of Erythropoietin from 2019 to 2021.
Chapter 3, the Erythropoietin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Erythropoietin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Erythropoietin market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Erythropoietin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Erythropoietin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Erythropoietin Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Epoetin-alfa
1.2.3 Epoetin-beta
1.2.4 Darbepoetin-alfa
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Erythropoietin Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Anemia
1.3.3 Kidney Disorders
1.3.4 Others
1.4 Global Erythropoietin Market Size & Forecast
1.4.1 Global Erythropoietin Sales in Value (2016-2026))
1.4.2 Global Erythropoietin Sales in Volume (2016-2026)
1.4.3 Global Erythropoietin Price by Type (2016-2026) & (US$/Unit)
1.5 Global Erythropoietin Production Capacity Analysis
1.5.1 Global Erythropoietin Total Production Capacity (2016-2026)
1.5.2 Global Erythropoietin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Erythropoietin Market Drivers
1.6.2 Erythropoietin Market Restraints
1.6.3 Erythropoietin Trends Analysis
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen Erythropoietin Product and Services
2.1.4 Amgen Erythropoietin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Erythropoietin Product and Services
2.2.4 Johnson & Johnson Erythropoietin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Erythropoietin Product and Services
2.3.4 Roche Erythropoietin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Galenica
2.4.1 Galenica Details
2.4.2 Galenica Major Business
2.4.3 Galenica Erythropoietin Product and Services
2.4.4 Galenica Erythropoietin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Emcure
2.5.1 Emcure Details
2.5.2 Emcure Major Business
2.5.3 Emcure Erythropoietin Product and Services
2.5.4 Emcure Erythropoietin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Kyowa Hakko Kirin
2.6.1 Kyowa Hakko Kirin Details
2.6.2 Kyowa Hakko Kirin Major Business
2.6.3 Kyowa Hakko Kirin Erythropoietin Product and Services
2.6.4 Kyowa Hakko Kirin Erythropoietin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 3SBio
2.7.1 3SBio Details
2.7.2 3SBio Major Business
2.7.3 3SBio Erythropoietin Product and Services
2.7.4 3SBio Erythropoietin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Biocon
2.8.1 Biocon Details
2.8.2 Biocon Major Business
2.8.3 Biocon Erythropoietin Product and Services
2.8.4 Biocon Erythropoietin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 LG Life Sciences
2.9.1 LG Life Sciences Details
2.9.2 LG Life Sciences Major Business
2.9.3 LG Life Sciences Erythropoietin Product and Services
2.9.4 LG Life Sciences Erythropoietin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Erythropoietin Sales by Manufacturer
3.1 Global Erythropoietin Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Erythropoietin Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Erythropoietin
3.4 Market Concentration Rate
3.4.1 Top 3 Erythropoietin Manufacturer Market Share
3.4.2 Top 6 Erythropoietin Manufacturer Market Share
3.5 Global Erythropoietin Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Erythropoietin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Erythropoietin Market Size by Region
4.1.1 Global Erythropoietin Sales in Volume by Region (2016-2026)
4.1.2 Global Erythropoietin Revenue by Region (2016-2026)
4.2 North America Erythropoietin Revenue (2016-2026)
4.3 Europe Erythropoietin Revenue (2016-2026)
4.4 Asia-Pacific Erythropoietin Revenue (2016-2026)
4.5 South America Erythropoietin Revenue (2016-2026)
4.6 Middle East and Africa Erythropoietin Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Erythropoietin Sales in Volume by Type (2016-2026)
5.2 Global Erythropoietin Revenue by Type (2016-2026)
5.3 Global Erythropoietin Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Erythropoietin Sales in Volume by Application (2016-2026)
6.2 Global Erythropoietin Revenue by Application (2016-2026)
6.3 Global Erythropoietin Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Erythropoietin Sales by Type (2016-2026)
7.2 North America Erythropoietin Sales by Application (2016-2026)
7.3 North America Erythropoietin Market Size by Country
7.3.1 North America Erythropoietin Sales in Volume by Country (2016-2026)
7.3.2 North America Erythropoietin Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Erythropoietin Sales by Type (2016-2026)
8.2 Europe Erythropoietin Sales by Application (2016-2026)
8.3 Europe Erythropoietin Market Size by Country
8.3.1 Europe Erythropoietin Sales in Volume by Country (2016-2026)
8.3.2 Europe Erythropoietin Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Erythropoietin Sales by Type (2016-2026)
9.2 Asia-Pacific Erythropoietin Sales by Application (2016-2026)
9.3 Asia-Pacific Erythropoietin Market Size by Region
9.3.1 Asia-Pacific Erythropoietin Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Erythropoietin Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Erythropoietin Sales by Type (2016-2026)
10.2 South America Erythropoietin Sales by Application (2016-2026)
10.3 South America Erythropoietin Market Size by Country
10.3.1 South America Erythropoietin Sales in Volume by Country (2016-2026)
10.3.2 South America Erythropoietin Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Erythropoietin Sales by Type (2016-2026)
11.2 Middle East & Africa Erythropoietin Sales by Application (2016-2026)
11.3 Middle East & Africa Erythropoietin Market Size by Country
11.3.1 Middle East & Africa Erythropoietin Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Erythropoietin Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Erythropoietin Typical Distributors
12.3 Erythropoietin Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Erythropoietin Revenue by Type, (USD Million), 2021-2026
Table 2. Global Erythropoietin Revenue by Application, (USD Million), 2021-2026
Table 3. Amgen Basic Information, Manufacturing Base and Competitors
Table 4. Amgen Major Business
Table 5. Amgen Erythropoietin Product and Services
Table 6. Amgen Erythropoietin Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 8. Johnson & Johnson Major Business
Table 9. Johnson & Johnson Erythropoietin Product and Services
Table 10. Johnson & Johnson Erythropoietin Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Roche Basic Information, Manufacturing Base and Competitors
Table 12. Roche Major Business
Table 13. Roche Erythropoietin Product and Services
Table 14. Roche Erythropoietin Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Galenica Basic Information, Manufacturing Base and Competitors
Table 16. Galenica Major Business
Table 17. Galenica Erythropoietin Product and Services
Table 18. Galenica Erythropoietin Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Emcure Basic Information, Manufacturing Base and Competitors
Table 20. Emcure Major Business
Table 21. Emcure Erythropoietin Product and Services
Table 22. Emcure Erythropoietin Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Kyowa Hakko Kirin Basic Information, Manufacturing Base and Competitors
Table 24. Kyowa Hakko Kirin Major Business
Table 25. Kyowa Hakko Kirin Erythropoietin Product and Services
Table 26. Kyowa Hakko Kirin Erythropoietin Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. 3SBio Basic Information, Manufacturing Base and Competitors
Table 28. 3SBio Major Business
Table 29. 3SBio Erythropoietin Product and Services
Table 30. 3SBio Erythropoietin Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Biocon Basic Information, Manufacturing Base and Competitors
Table 32. Biocon Major Business
Table 33. Biocon Erythropoietin Product and Services
Table 34. Biocon Erythropoietin Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. LG Life Sciences Basic Information, Manufacturing Base and Competitors
Table 36. LG Life Sciences Major Business
Table 37. LG Life Sciences Erythropoietin Product and Services
Table 38. LG Life Sciences Erythropoietin Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Erythropoietin Sales by Manufacturer (2019-2021e) & (M Units)
Table 40. Global Erythropoietin Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Erythropoietin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Erythropoietin Production Capacity by Company, (M Units): 2020 VS 2021
Table 43. Head Office and Erythropoietin Production Site of Key Manufacturer
Table 44. Erythropoietin New Entrant and Capacity Expansion Plans
Table 45. Erythropoietin Mergers & Acquisitions in the Past Five Years
Table 46. Global Erythropoietin Sales by Region (2016-2021e) & (M Units)
Table 47. Global Erythropoietin Sales by Region (2021-2026) & (M Units)
Table 48. Global Erythropoietin Revenue by Region (2016-2021e) & (USD Million)
Table 49. Global Erythropoietin Revenue by Region (2021-2026) & (USD Million)
Table 50. Global Erythropoietin Sales by Type (2016-2021e) & (M Units)
Table 51. Global Erythropoietin Sales by Type (2021-2026) & (M Units)
Table 52. Global Erythropoietin Revenue by Type (2016-2021e) & (USD Million)
Table 53. Global Erythropoietin Revenue by Type (2021-2026) & (USD Million)
Table 54. Global Erythropoietin Price by Type (2016-2021e) & (US$/Unit)
Table 55. Global Erythropoietin Price by Type (2021-2026) & (US$/Unit)
Table 56. Global Erythropoietin Sales by Application (2016-2021e) & (M Units)
Table 57. Global Erythropoietin Sales by Application (2021-2026) & (M Units)
Table 58. Global Erythropoietin Revenue by Application (2016-2021e) & (USD Million)
Table 59. Global Erythropoietin Revenue by Application (2021-2026) & (USD Million)
Table 60. Global Erythropoietin Price by Application (2016-2021e) & (US$/Unit)
Table 61. Global Erythropoietin Price by Application (2021-2026) & (US$/Unit)
Table 62. North America Erythropoietin Sales by Country (2016-2021e) & (M Units)
Table 63. North America Erythropoietin Sales by Country (2021-2026) & (M Units)
Table 64. North America Erythropoietin Revenue by Country (2016-2021e) & (USD Million)
Table 65. North America Erythropoietin Revenue by Country (2021-2026) & (USD Million)
Table 66. North America Erythropoietin Sales by Type (2016-2021e) & (M Units)
Table 67. North America Erythropoietin Sales by Type (2021-2026) & (M Units)
Table 68. North America Erythropoietin Sales by Application (2016-2021e) & (M Units)
Table 69. North America Erythropoietin Sales by Application (2021-2026) & (M Units)
Table 70. Europe Erythropoietin Sales by Country (2016-2021e) & (M Units)
Table 71. Europe Erythropoietin Sales by Country (2021-2026) & (M Units)
Table 72. Europe Erythropoietin Revenue by Country (2016-2021e) & (USD Million)
Table 73. Europe Erythropoietin Revenue by Country (2021-2026) & (USD Million)
Table 74. Europe Erythropoietin Sales by Type (2016-2021e) & (M Units)
Table 75. Europe Erythropoietin Sales by Type (2021-2026) & (M Units)
Table 76. Europe Erythropoietin Sales by Application (2016-2021e) & (M Units)
Table 77. Europe Erythropoietin Sales by Application (2021-2026) & (M Units)
Table 78. Asia-Pacific Erythropoietin Sales by Region (2016-2021e) & (M Units)
Table 79. Asia-Pacific Erythropoietin Sales by Region (2021-2026) & (M Units)
Table 80. Asia-Pacific Erythropoietin Revenue by Region (2016-2021e) & (USD Million)
Table 81. Asia-Pacific Erythropoietin Revenue by Region (2021-2026) & (USD Million)
Table 82. Asia-Pacific Erythropoietin Sales by Type (2016-2021e) & (M Units)
Table 83. Asia-Pacific Erythropoietin Sales by Type (2021-2026) & (M Units)
Table 84. Asia-Pacific Erythropoietin Sales by Application (2016-2021e) & (M Units)
Table 85. Asia-Pacific Erythropoietin Sales by Application (2021-2026) & (M Units)
Table 86. South America Erythropoietin Sales by Country (2016-2021e) & (M Units)
Table 87. South America Erythropoietin Sales by Country (2021-2026) & (M Units)
Table 88. South America Erythropoietin Revenue by Country (2016-2021e) & (USD Million)
Table 89. South America Erythropoietin Revenue by Country (2021-2026) & (USD Million)
Table 90. South America Erythropoietin Sales by Type (2016-2021e) & (M Units)
Table 91. South America Erythropoietin Sales by Type (2021-2026) & (M Units)
Table 92. South America Erythropoietin Sales by Application (2016-2021e) & (M Units)
Table 93. South America Erythropoietin Sales by Application (2021-2026) & (M Units)
Table 94. Middle East & Africa Erythropoietin Sales by Country (2016-2021e) & (M Units)
Table 95. Middle East & Africa Erythropoietin Sales by Country (2021-2026) & (M Units)
Table 96. Middle East & Africa Erythropoietin Revenue by Country (2016-2021e) & (USD Million)
Table 97. Middle East & Africa Erythropoietin Revenue by Country (2021-2026) & (USD Million)
Table 98. Middle East & Africa Erythropoietin Sales by Type (2016-2021e) & (M Units)
Table 99. Middle East & Africa Erythropoietin Sales by Type (2021-2026) & (M Units)
Table 100. Middle East & Africa Erythropoietin Sales by Application (2016-2021e) & (M Units)
Table 101. Middle East & Africa Erythropoietin Sales by Application (2021-2026) & (M Units)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Erythropoietin Typical Distributors
Table 105. Erythropoietin Typical Customers
List of Figures
Figure 1. Erythropoietin Picture
Figure 2. Global Erythropoietin Sales Market Share by Type in 2020
Figure 3. Epoetin-alfa
Figure 4. Epoetin-beta
Figure 5. Darbepoetin-alfa
Figure 6. Others
Figure 7. Global Erythropoietin Sales Market Share by Application in 2020
Figure 8. Anemia
Figure 9. Kidney Disorders
Figure 10. Others
Figure 11. Global Erythropoietin Market Size, (USD Million) & (M Units): 2020 VS 2021 VS 2026
Figure 12. Global Erythropoietin Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. Global Erythropoietin Sales (2016-2026) & (M Units)
Figure 14. Global Erythropoietin Price by Type (2016-2026) & (US$/Unit)
Figure 15. Global Erythropoietin Production Capacity (2016-2026) & (M Units)
Figure 16. Global Erythropoietin Production Capacity by Geographic Region: 2020 VS 2021
Figure 17. Erythropoietin Market Drivers
Figure 18. Erythropoietin Market Restraints
Figure 19. Erythropoietin Market Trends
Figure 20. Global Erythropoietin Sales Market Share by Manufacturer in 2020
Figure 21. Global Erythropoietin Revenue Market Share by Manufacturer in 2020
Figure 22. Erythropoietin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 23. Top 3 Erythropoietin Manufacturer (Revenue) Market Share in 2020
Figure 24. Top 6 Erythropoietin Manufacturer (Revenue) Market Share in 2020
Figure 25. Global Erythropoietin Sales Market Share by Region (2016-2026)
Figure 26. Global Erythropoietin Revenue Market Share by Region (2016-2026)
Figure 27. North America Erythropoietin Revenue (2016-2026) & (USD Million)
Figure 28. Europe Erythropoietin Revenue (2016-2026) & (USD Million)
Figure 29. Asia-Pacific Erythropoietin Revenue (2016-2026) & (USD Million)
Figure 30. South America Erythropoietin Revenue (2016-2026) & (USD Million)
Figure 31. Middle East & Africa Erythropoietin Revenue (2016-2026) & (USD Million)
Figure 32. Global Erythropoietin Sales Market Share by Type (2016-2026)
Figure 33. Global Erythropoietin Revenue Market Share by Type (2016-2026)
Figure 34. Global Erythropoietin Price by Type (2016-2026) & (US$/Unit)
Figure 35. Global Erythropoietin Sales Market Share by Application (2016-2026)
Figure 36. Global Erythropoietin Revenue Market Share by Application (2016-2026)
Figure 37. Global Erythropoietin Price by Application (2016-2026) & (US$/Unit)
Figure 38. North America Erythropoietin Sales Market Share by Type (2016-2026)
Figure 39. North America Erythropoietin Sales Market Share by Application (2016-2026)
Figure 40. North America Erythropoietin Sales Market Share by Country (2016-2026)
Figure 41. North America Erythropoietin Revenue Market Share by Country (2016-2026)
Figure 42. United States Erythropoietin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Erythropoietin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Erythropoietin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Erythropoietin Sales Market Share by Type (2016-2026)
Figure 46. Europe Erythropoietin Sales Market Share by Application (2016-2026)
Figure 47. Europe Erythropoietin Sales Market Share by Country (2016-2026)
Figure 48. Europe Erythropoietin Revenue Market Share by Country (2016-2026)
Figure 49. Germany Erythropoietin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Erythropoietin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Erythropoietin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Erythropoietin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Erythropoietin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Erythropoietin Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Erythropoietin Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Erythropoietin Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Erythropoietin Revenue Market Share by Region (2016-2026)
Figure 58. China Erythropoietin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Erythropoietin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Korea Erythropoietin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Erythropoietin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Erythropoietin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Erythropoietin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Erythropoietin Sales Market Share by Type (2016-2026)
Figure 65. South America Erythropoietin Sales Market Share by Application (2016-2026)
Figure 66. South America Erythropoietin Sales Market Share by Country (2016-2026)
Figure 67. South America Erythropoietin Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Erythropoietin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Erythropoietin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East & Africa Erythropoietin Sales Market Share by Type (2016-2026)
Figure 71. Middle East & Africa Erythropoietin Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Erythropoietin Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Erythropoietin Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Erythropoietin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Egypt Erythropoietin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Erythropoietin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. South Africa Erythropoietin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source

---